ZYBERNO
Stock Report
Updated Aug 23, 2026

IceCure Medical Ltd. (ICCM)

Healthcare • NASDAQ

$2.43

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
18.0/100
POOR BUSINESS
IceCure Medical Ltd. (ICCM) scores 18/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.05x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-770.6%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

IceCure Medical Ltd. (ICCM) stock report — Zyberno Score 18/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:2.43
Market Cap:$6.64M

Valuation Multiples (3)

P/B Ratio:0.73x
P/S Ratio:1.96x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:-$942.39K

Price Action & Momentum (3)

Momentum Percentile:1 / 100
% of 52-Week High:5.8%
B. Profitability Assessment

Return Metrics (3)

Reinvestment Rate:2.3%
Fundamental Growth Rate (g):-17.6%

Margin Analysis (1)

Ebitda Margin:-438.0%

Yield Metrics (2)

Earnings Yield:-$999.00
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:2.61x
Quick Ratio:2.07x
Cash Ratio:1.84x

Leverage Analysis (3)

Debt To Equity Ttm:0.05x
Debt-to-Equity Ratio:0.05x
Debt To Ebitda:-999.00x

Coverage Ratios (1)

Times Interest Earned:-999.00

Capital Structure (4)

Working Capital:7,781,000.00
Cash And Cash Equivalents:8,897,000.00
Long Term Debt:$217.00K
Net Debt:-$7.58M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$3.38M
Cost Of Revenue Ttm:$2.15M

Profitability Breakdown (2)

$1.23M-$15.09M

Bottom Line Performance (3)

-$15.06M
Income Before Tax:$0.00
Ebitda Ttm:-14,799,000.00

Operating Expenses (5)

Operating Expenses:0.00
R And D Expense:7,433,000.00
Sga Expense:4,529,000.00
Income Tax Expense:$0.00
Interest Expense:0.00

Expense Ratios (3)

R And D To Revenue Percentage:220.0%
Sga To Revenue Percentage:134.0%
Ebitda Margin:-438.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$13.89M
Current Assets:$12.61M
Ppe Net:993,000.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:4,837,000.00
Current Liabilities:4,824,000.00
Long Term Debt:$217.00K
Short Term Debt:$1.10M

Equity & Capital (3)

Equity:$9.05M
Retained Earnings:-$120.44M
Common Stock:2,500,000,000.00

Working Capital Items (3)

Accounts Receivable:331,000.00
Inventory:2,625,000.00
Accounts Payable:0.00

Special Items (2)

Contract Liabilities:255,000.00
Stock Based Compensation:1,373,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$14.57M-$14.61M

Investment Activities (1)

Investing Cash Flow:-$36.00K

Financing Activities (3)

Financing Cash Flow:$15.83M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:10,000,000.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:295,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (1)

Earnings Per Share Ttm:-$5.51

Revenue & Cash Per Share (2)

Sales Per Share Ttm:1.24
Operating Cash Flow Per Share:-$5.33

Book Value & Capital (2)

Book Value Per Share:$3.31
Cash Per Share:3.26

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.24x
Working Capital Turnover Ttm:0.43x

Receivables Management (2)

Receivables Turnover Ttm:10.21x
Days Sales Outstanding Ttm:35.75

Inventory Management (2)

Inventory Turnover Ttm:0.82x
Days Inventory Outstanding Ttm:445.02

Payables & Cash Cycle (2)

Days Payable Outstanding:-999.00
Cash Conversion Cycle:1,479.77
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:40.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:2.3%
Fundamental Growth Rate (g):-17.6%
B. Log-Linear Regression Growth Analysis
C. Company Profile & Context

Corporate Information (6)

Symbol:ICCM
Company Name:IceCure Medical Ltd.
Sector:Healthcare
Industry:Medical Devices
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:2.73M
Shares Outstanding Basic:63.58M
Shares Outstanding Diluted:63.58M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-23 04:18:44 UTC
Data Timestamp:2026-08-21T21:08:37.224749
Scroll to Top